Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma

Published:2019-11-07 Issue:1 Volume:95 Page:57-67
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Abdulla Maysaa¹,Hollander Peter¹^ORCID,Pandzic Tatjana²,Mansouri Larry³,Ednersson Susanne Bram⁴,Andersson Per‐Ola⁵⁶,Hultdin Magnus⁷,Fors Maja⁷,Erlanson Martin⁸,Degerman Sofie⁷^ORCID,Petersen Helga Munch⁹,Asmar Fazila¹⁰,Grønbæk Kirsten¹⁰,Enblad Gunilla¹¹,Cavelier Lucia²,Rosenquist Richard³,Amini Rose‐Marie¹

Affiliation:

1. Clinical and Experimental Pathology, Department of Immunology, Genetics and PathologyUppsala University Uppsala Sweden

2. Medical Genetics and Genomics, Department of Immunology, Genetics and PathologyUppsala University Uppsala Sweden

3. Department of Molecular Medicine and SurgeryKarolinska Institute Stockholm Sweden

4. Department of PathologySahlgrenska University Hospital Gothenburg Sweden

5. Sahlgrenska Academy at the University of Gothenburg Gothenburg Sweden

6. Department of MedicineSödra Älvsborg Hospital Borås Borås Sweden

7. Department of Medical BiosciencesPathology, Umeå University Umeå Sweden

8. Department of Radiation Sciences, OncologyUmeå University Umeå Sweden

9. Department of PathologyCopenhagen University Hospital, Rigshospitalet Copenhagen Denmark

10. Department of HematologyCopenhagen University Hospital, Rigshospitalet Copenhagen Denmark

11. Experimental and Clinical Oncology, Department of Immunology, Genetics and PathologyUppsala University Uppsala Sweden

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25666

Reference40 articles.

1. Diffuse large B-cell lymphoma

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

3. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

4. Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 Update: Advances in the risk stratification and management of large B‐cell lymphoma;American Journal of Hematology;2023-08-30

2. Role of interim PET/CT as predictor of outcome in newly diagnosed diffuse large b-cell lymphoma in the chemo-immunotherapy era;Current Research in Translational Medicine;2023-07

3. Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective study;Translational Cancer Research;2023-06

4. Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas;Human Pathology;2023-06

5. High density of FOXP3 predicts better prognosis in germinal and non‐germinal centre diffuse large B‐cell lymphoma;International Journal of Experimental Pathology;2023-03-28